IDEXX Laboratories, Inc. provided earnings guidance for the year 2022. For the year, the company expected to reported revenue of $3,305 million to $3,385 million and EPS to be $7.77 to $8.05.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
548.5 USD | +5.26% | +12.62% | -1.17% |
May. 14 | Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620 | MT |
May. 02 | BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653 | MT |
EPS Revisions
- Stock Market
- Equities
- IDXX Stock
- News IDEXX Laboratories, Inc.
- IDEXX Laboratories, Inc. Provides Earnings Guidance for the Year 2022